117 related articles for article (PubMed ID: 4049479)
1. The C57BL/6 nu/nu lpr/lpr mouse. II. Pedigree and preliminary characteristics.
Mosbach-Ozmen L; Fonteneau P; Loor F
Thymus; 1985; 7(4):233-45. PubMed ID: 4049479
[TBL] [Abstract][Full Text] [Related]
2. The C57BL/6 nu/nu lpr/lpr mouse. I. Expression of the 'lpr phenotype' in the C57BL/6 genetic background.
Mosbach-Ozmen L; Fonteneau P; Loor F
Thymus; 1985; 7(4):221-32. PubMed ID: 3876624
[TBL] [Abstract][Full Text] [Related]
3. Lymphoid cell transfers between adult C57BL/6 mice differing at the LPR locus. Lack of lymphadenopathy transfer and effects on host survival.
Montecino-Rodriguez E; Jachez B; Loor F
Thymus; 1988; 11(2):89-111. PubMed ID: 3259028
[TBL] [Abstract][Full Text] [Related]
4. The C57B1/6 nu/nu, lpr/lpr mouse. III. Autoimmunity status.
Mosbach-Ozmen L; Gaveriaux C; Montecino-Rodriguez E; Loor F
Thymus; 1986; 8(1-2):59-75. PubMed ID: 3088780
[TBL] [Abstract][Full Text] [Related]
5. Serum immunoglobulin isotype profile of viable and non viable lymphoid cell chimaeras made with nude athymic lpr (lymphoproliferation) mouse recipients.
Tiberghien F; Jachez B; Montecino-Rodriguez E; Loor F
Autoimmunity; 1992; 11(3):151-8. PubMed ID: 1571477
[TBL] [Abstract][Full Text] [Related]
6. Lack of transfer of lpr-type abnormalities (lymphoproliferation or lymphoid aplasia) in double congenic nude beige mice engrafted with lpr haematopoietic cells.
Tiberghien F; Pflumio F; Kuntz L; Loor F
Immunology; 1993 May; 79(1):158-66. PubMed ID: 8099566
[TBL] [Abstract][Full Text] [Related]
7. Lymphoid cell transfers between adult C57BL/6 mice differing at the lpr and/or nu locus. Humoral immunity phenotype of the chimeras.
Jachez B; Montecino-Rodriguez E; Pflumio F; Fonteneau P; Loor F
Immunology; 1989 Oct; 68(2):169-74. PubMed ID: 2807374
[TBL] [Abstract][Full Text] [Related]
8. Haematopoietic cell transfers between C57BL/6 mice differing at the lpr or gld locus.
Montecino-Rodriguez EM; Loor F
Immunology; 1991 Sep; 74(1):127-31. PubMed ID: 1682243
[TBL] [Abstract][Full Text] [Related]
9. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.
Gu L; Weinreb A; Wang XP; Zack DJ; Qiao JH; Weisbart R; Lusis AJ
J Immunol; 1998 Dec; 161(12):6999-7006. PubMed ID: 9862736
[TBL] [Abstract][Full Text] [Related]
10. Tetraparental mice reveal complex cellular interactions of the mutant, autoimmunity-inducing lpr gene.
Katagiri T; Azuma S; Toyoda Y; Mori S; Kano K; Cohen PL; Eisenberg RA
J Immunol; 1992 Jan; 148(2):430-8. PubMed ID: 1729363
[TBL] [Abstract][Full Text] [Related]
11. Lpr and MRL background gene involvement in the control of adjuvant enhanced arthritis in MRL-lpr mice.
Ratkay LG; Tait B; Tonzetich J; Waterfield JD
J Autoimmun; 1994 Oct; 7(5):561-73. PubMed ID: 7530961
[TBL] [Abstract][Full Text] [Related]
12. Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha.
Rifkin IR; Channavajhala PL; Kiefer HL; Carmack AJ; Landesman-Bollag E; Beaudette BC; Jersky B; Salant DJ; Ju ST; Marshak-Rothstein A; Seldin DC
J Immunol; 1998 Nov; 161(10):5164-70. PubMed ID: 9820486
[TBL] [Abstract][Full Text] [Related]
13. A crucial role of the thymus in induction by the lprcg gene of lymphadenopathy with autoimmunity in the mouse.
Matsuzawa A; Moriyama T; Ogata Y; Katagiri T; Kimura M
Immunology; 1992 Apr; 75(4):688-92. PubMed ID: 1592441
[TBL] [Abstract][Full Text] [Related]
14. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
[TBL] [Abstract][Full Text] [Related]
15. Immunological and pathological consequences of mutations in both Fas and Fas ligand.
Weintraub JP; Godfrey V; Wolthusen PA; Cheek RL; Eisenberg RA; Cohen PL
Cell Immunol; 1998 May; 186(1):8-17. PubMed ID: 9637760
[TBL] [Abstract][Full Text] [Related]
16. The effect of the genetic background on the development and function of accumulating YE1/19.1+ cells in lpr mice.
Kaminski DA; Waterfield JD
Thymus; 1991 Feb; 17(1):23-37. PubMed ID: 2014521
[TBL] [Abstract][Full Text] [Related]
17. In vivo CD4+ lymph node T cells from lpr mice generate CD4-CD8-B220+TCR-beta low cells.
Laouar Y; Ezine S
J Immunol; 1994 Nov; 153(9):3948-55. PubMed ID: 7523511
[TBL] [Abstract][Full Text] [Related]
18. The lpr gene causes an intrinsic T cell abnormality that is required for hyperproliferation.
Katagiri T; Cohen PL; Eisenberg RA
J Exp Med; 1988 Mar; 167(3):741-51. PubMed ID: 3258351
[TBL] [Abstract][Full Text] [Related]
19. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin isotypes of C57BL/6 nu/nu, lpr/lpr mice. Lack of direct intrinsic effect of the lpr gene on B cell hyperactivity.
Trembleau S; Pflumio F; Kuntz L; Jachez B; Loor F
Autoimmunity; 1991; 9(2):165-70. PubMed ID: 1932523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
